Xu L, He B, Sun Y, Li J, Shen P, Hu L, Liu G, Wang J, Duan L, Zhan S, Wang S. Incidence of inflammatory bowel disease in urban China: a nationwide population-based study. Clin Gastroenterol Hepatol. 2023;21(3379–3386):e3329. https://doi.org/10.1016/j.cgh.2023.08.013.
Long D. Crohn’s disease and ulcerative colitis: from pathophysiology to novel therapeutic approaches. Biomedicines. 2024. https://doi.org/10.3390/biomedicines12030689.
Article PubMed PubMed Central Google Scholar
Zeitz J, Ak M, Muller-Mottet S, Scharl S, Biedermann L, Fournier N, Frei P, Pittet V, Scharl M, Fried M, Rogler G, Vavricka S, Swiss IBD. Pain in IBD patients: very frequent and frequently insufficiently taken into account. PLoS ONE. 2016;11: e0156666. https://doi.org/10.1371/journal.pone.0156666.
Article CAS PubMed PubMed Central Google Scholar
Coates MD, Johri A, Gorrepati VS, Maheshwari P, Dalessio S, Walter V, Stuart A, Koltun W, Bernasko N, Tinsley A, Williams ED, Clarke K. Abdominal pain in quiescent inflammatory bowel disease. Int J Colorectal Dis. 2021;36:93–102. https://doi.org/10.1007/s00384-020-03727-3.
Camilleri M, Lembo A, Katzka DA. Opioids in gastroenterology: treating adverse effects and creating therapeutic benefits. Clin Gastroenterol Hepatol. 2017;15:1338–49. https://doi.org/10.1016/j.cgh.2017.05.014.
Article CAS PubMed PubMed Central Google Scholar
Baillie S, Norton C, Saxena S, Pollok R. Chronic abdominal pain in inflammatory bowel disease: a practical guide. Frontline Gastroenterol. 2024;15:144–53. https://doi.org/10.1136/flgastro-2023-102471.
Szigethy E, Knisely M, Drossman D. Opioid misuse in gastroenterology and non-opioid management of abdominal pain. Nat Rev Gastroenterol Hepatol. 2018;15:168–80. https://doi.org/10.1038/nrgastro.2017.141.
Jozwiak-Bebenista M, Nowak JZ. Paracetamol: mechanism of action, applications and safety concern. Acta Pol Pharm. 2014;71:11–23.
Norton C, Czuber-Dochan W, Artom M, Sweeney L, Hart A. Systematic review: interventions for abdominal pain management in inflammatory bowel disease. Aliment Pharmacol Ther. 2017;46:115–25. https://doi.org/10.1111/apt.14108.
Article CAS PubMed Google Scholar
Takahashi K, Khwaja IG, Schreyer JR, Bulmer D, Peiris M, Terai S, Aziz Q. Post-inflammatory abdominal pain in patients with inflammatory bowel disease during remission: a comprehensive review. Crohns Colitis. 2021;3:73. https://doi.org/10.1093/crocol/otab073.
Szigethy E. Pain management in patients with inflammatory bowel disease. Gastroenterol Hepatol (N Y). 2018;14:53–6.
Hiraoka S, Fujiwara A, Toyokawa T, Higashi R, Moritou Y, Takagi S, Matsueda K, Suzuki S, Miyaike J, Inokuchi T, Takahara M, Kato J, Okada H. Multicenter survey on mesalamine intolerance in patients with ulcerative colitis. J Gastroenterol Hepatol. 2021;36:137–43. https://doi.org/10.1111/jgh.15138.
Article CAS PubMed Google Scholar
Peng S, Xia Y, Wang Y, Yu X, Wu Z, Zhang L, Xu K, Shen L, Luo H. Research hotspots and trend analysis of abdominal pain in inflammatory bowel disease: a bibliometric and visualized analysis. Front Pharmacol. 2023;14:1220418. https://doi.org/10.3389/fphar.2023.1220418.
Article PubMed PubMed Central Google Scholar
Ford AC, Vanner S, Kashyap PC, Nasser Y. Chronic visceral pain: new peripheral mechanistic insights and resulting treatments. Gastroenterology. 2024. https://doi.org/10.1053/j.gastro.2024.01.045.
Zubrzycka I, Bogale K, Stuart A, Cesaire M, Walter V, Dalessio S, Tinsley A, Williams E, Clarke K, Coates MD. Abdominal pain is associated with an increased risk of future healthcare resource utilization in inflammatory bowel disease. Int J Colorectal Dis. 2023;38:213. https://doi.org/10.1007/s00384-023-04510-w.
Ananthakrishnan AN, Xavier RJ, Podolsky DK: Inflammatory bowel diseases : a clinician's guide. Chichester, West Sussex, UK ; Hoboken, NJ, John Wiley & Sons, Inc.,; 2017; pp. 27+41.
Aziz Q, Giamberardino MA, Barke A, Korwisi B, Baranowski AP, Wesselmann U, Rief W, Treede RD, Pain ITC. The IASP classification of chronic pain for ICD-11: chronic secondary visceral pain. Pain. 2019;160:69–76. https://doi.org/10.1097/j.pain.0000000000001362.
Gans SL, Pols MA, Stoker J, Boermeester MA. Guideline for the diagnostic pathway in patients with acute abdominal pain. Dig Surg. 2015;32:23–31. https://doi.org/10.1159/000371583.
Hardy PY, Fikri J, Libbrecht D, Louis E, Joris J. Pain characteristics in patients with inflammatory bowel disease: a monocentric cross-sectional study. J Crohns Colitis. 2022;16:1363–71. https://doi.org/10.1093/ecco-jcc/jjac051.
Singh S, Blanchard A, Walker JR, Graff LA, Miller N, Bernstein CN. Common symptoms and stressors among individuals with inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2011;9:769–75. https://doi.org/10.1016/j.cgh.2011.05.016.
Coates MD, Lahoti M, Binion DG, Szigethy EM, Regueiro MD, Bielefeldt K. Abdominal pain in ulcerative colitis. Inflamm Bowel Dis. 2013;19:2207–14. https://doi.org/10.1097/MIB.0b013e31829614c6.
Greenley RN, Kunz JH, Schurman JV, Swanson E. Abdominal pain and health-related quality of life in pediatric inflammatory bowel disease. J Pediatr Psychol. 2013;38:63–71. https://doi.org/10.1093/jpepsy/jss097.
Ding Z, Patel A, Izanec J, Pericone CD, Lin JH, Baugh CW. Trends in US emergency department visits and subsequent hospital admission among patients with inflammatory bowel disease presenting with abdominal pain: a real-world study from a national emergency department sample database. J Mark Access Health Policy. 2021;9:1912924. https://doi.org/10.1080/20016689.2021.1912924.
Article PubMed PubMed Central Google Scholar
Newton L, Randall JA, Hunter T, Keith S, Symonds T, Secrest RJ, Komocsar WJ, Curtis SE, Abetz-Webb L, Kappelman M, Naegeli AN. A qualitative study exploring the health-related quality of life and symptomatic experiences of adults and adolescents with ulcerative colitis. J Patient Rep Outcomes. 2019;3:66. https://doi.org/10.1186/s41687-019-0154-x.
Article PubMed PubMed Central Google Scholar
Gorrepati VS, Soriano C, Johri A, Dalessio S, Stuart A, Koltun W, Tinsley A, Clarke K, Williams E, Coates M. Abdominal pain and anxious or depressed state are independently associated with weight loss in inflammatory bowel disease. Crohns Colitis. 2020;2:47. https://doi.org/10.1093/crocol/otaa047.
Barnes A, Andrews JM, Mukherjee S, Bryant RV, Bampton P, Fraser RJ, Mountifield R. Insomnia is common in inflammatory bowel disease (IBD) and is associated with mental health conditions as well as IBD activity. Intest Res. 2024;22:104–14. https://doi.org/10.5217/ir.2023.00028.
Louis E, Siegel CA, James B, Heidenreich S, Krucien N, Ghosh S. Patients with inflammatory bowel disease have heterogeneous treatment preferences that are largely determined by the avoidance of abdominal pain and side effects [P-POWER IBD Study]. J Crohns Colitis. 2023;17:231–9. https://doi.org/10.1093/ecco-jcc/jjac130.
Yeung AWK, Wong NSM. The historical roots of visual analog scale in psychology as revealed by reference publication year spectroscopy. Front Hum Neurosci. 2019;13:86. https://doi.org/10.3389/fnhum.2019.00086.
Article PubMed PubMed Central Google Scholar
Li W, Qing Z, Jun C, Bifa F, Chongrong G, Li H, Yi J, Rongguo L, Guijun L, Tao S, Wei T, Jianglin W, Lin W, Jun W, Dasheng W, Xiaoqiu Y. Expert consensus on the application of pain evaluation questionnaires in China (2020). Chin J Painol. 2020;16:8. https://doi.org/10.3760/cma.j.cn101379-20190915-00075.
Bengtsson M, Hammar O, Mandl T, Ohlsson B. Evaluation of gastrointestinal symptoms in different patient groups using the visual analogue scale for irritable bowel syndrome (VAS-IBS). BMC Gastroenterol. 2011;11:122. https://doi.org/10.1186/1471-230X-11-122.
Article PubMed PubMed Central Google Scholar
Sung YT, Wu JS. The Visual analogue scale for rating, ranking and paired-comparison (VAS-RRP): a new technique for psychological measurement. Behav Res Methods. 2018;50:1694–715. https://doi.org/10.3758/s13428-018-1041-8.
Comments (0)